4.2 Article

circGFRA1 affects the sensitivity of triple-negative breast cancer cells to paclitaxel via the miR-361-5p/TLR4 pathway

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

circGFRA1 and GFRA1 act as ceRNAs in triple negative breast cancer by regulating miR-34a

Rongfang He et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)

Article Oncology

Effect of curcumin and paclitaxel on breast carcinogenesis

Edgar Teddy Quispe-Soto et al.

INTERNATIONAL JOURNAL OF ONCOLOGY (2016)

Review Genetics & Heredity

The Emerging Function and Mechanism of ceRNAs in Cancer

Yunfei Wang et al.

TRENDS IN GENETICS (2016)

Article Biochemistry & Molecular Biology

MiR-361-5p acts as a tumor suppressor in prostate cancer by targeting signal transducer and activator of transcription-6(STAT6)

Dachuang Liu et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)

Review Multidisciplinary Sciences

The multilayered complexity of ceRNA crosstalk and competition

Yvonne Tay et al.

NATURE (2014)

Review Biotechnology & Applied Microbiology

Detecting and characterizing circular RNAs

William R. Jeck et al.

NATURE BIOTECHNOLOGY (2014)

Article Oncology

TLR4 Is a Novel Determinant of the Response to Paclitaxel in Breast Cancer

Sandeep Rajput et al.

MOLECULAR CANCER THERAPEUTICS (2013)

Article Pharmacology & Pharmacy

The expression profile of ATP-binding cassette transporter genes in breast carcinoma

Viktor Hlavac et al.

PHARMACOGENOMICS (2013)

Review Oncology

Biomarkers and multiple drug resistance in breast cancer

L. O'Driscoll et al.

CURRENT CANCER DRUG TARGETS (2006)